Lipid nanocapsules loaded with prilocaine and lidocaine and incorporated in gel for topical application.

International Journal of Pharmaceutics
Priscila Cordeiro Lima FernandesEneida de Paula

Abstract

Lipid nanocapsules (LNC) are special drug delivery system (DDS) carriers obtained by the phase-inversion temperature method (PIT). This study describes the encapsulation of the local anesthetics (LA) prilocaine (PLC) and lidocaine (LDC) in lipid nanocapsules (LNCPLC+LDC) optimized by 23 factorial design, characterized through DLS, NTA, CRYO-EM and release kinetics and incorporated in carbopol gel (GelLNC PLC+LDC) prior to in vivo anesthetic effect (in mice) evaluation. A very homogeneous population of small (50 nm; polydispersity index = 0.05) spherical nanocapsules with negative zeta potentials (-21 mV) and ca. 2.3 × 1015 particles/mL was obtained. The encapsulation efficiency was high (81% and 89% for prilocaine and lidocaine, respectively). The release rate profile was free PLC = free LDC > LNCPLC+LDC > GelLNC PLC+LDC. The hybrid system increased (4x) the anesthesia time in comparison to an equipotent gel formulation prepared without LNC. No tissue damage was detected on the tail skin of mice that received the formulations. This study shows that lipid nanocapsules are suitable carriers for PLC and LDC, promoting longer and safer topical anesthesia. GelLNC PLC+LDC is mucoadhesive and suitable for application in the mouth, whe...Continue Reading

References

Jan 1, 1991·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·C A Squier
Apr 12, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·P Costa, J M Sousa Lobo
Jul 24, 2002·Pharmaceutical Research·Béatrice HeurtaultJean-Pierre Benoit
Dec 19, 2002·Biochimica Et Biophysica Acta·Aneta D Petelska, Zbigniew A Figaszewski
Jan 30, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Béatrice HeurtaultJean-Pierre Benoît
Dec 27, 2005·International Journal of Pharmaceutics·Vasiliki PapadopoulouPanos Macheras
Feb 12, 2008·British Dental Journal·M Franz-MontanF C Groppo
May 13, 2008·Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Société Canadienne Des Sciences Pharmaceutiques·Mohammad Barzegar-JalaliMaryam Hasan
May 5, 2009·International Journal of Pharmaceutics·N T HuynhJ P Benoit
May 12, 2009·International Journal of Pharmaceutics·Qingzhi LvGuangxi Zhai
Aug 22, 2009·British Journal of Clinical Pharmacology·Sindy TrauerJürgen Lademann
Feb 13, 2010·International Journal of Pharmaceutics·Mona M A Abdel-MottalebAlf Lamprecht
Apr 28, 2010·Pharmaceutical Research·Daniele Ribeiro de AraujoPatrizia Santi
Jan 1, 2009·IEEE Reviews in Biomedical Engineering·Metin N GurcanB Yener
Nov 26, 2010·The British Journal of Oral & Maxillofacial Surgery·M Franz-MontanM C Volpato
Dec 17, 2011·Journal of Drug Delivery·Jaleh VarshosazSindokht Soltanzadeh
Jan 17, 2012·Neuroscience·M Barrot
Oct 17, 2012·International Journal of Pharmaceutical Investigation·Gaurav TiwariSaurabh K Bannerjee
Dec 10, 2013·Frontiers in Pharmacology·Susan Hua, Sherry Y Wu
May 27, 2014·International Journal of Pharmaceutics·Yingjie ZhaiGuangxi Zhai
Jun 26, 2015·European Journal of Dermatology : EJD·Emmanuelle LemeryMarie-Alexandrine Bolzinger
Oct 28, 2015·Advanced Pharmaceutical Bulletin·Neda NaseriParvin Zakeri-Milani
Feb 24, 2016·International Journal of Pharmaceutics·Nada MatouguiPatrick Saulnier
Jun 25, 2016·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Phoebe L Stewart
Aug 21, 2016·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Lígia N M RibeiroEneida de Paula
Aug 25, 2016·Expert Opinion on Drug Delivery·Michelle Franz-MontanEneida de Paula
Oct 25, 2016·International Journal of Pharmaceutics·Benjamin BalzusRoland Bodmeier
May 1, 2017·International Journal of Pharmaceutics·Reatul KarimGéraldine Piel
May 17, 2017·Biophysics Reviews·Jörg StetefeldTrushar R Patel
Aug 11, 2017·PloS One·Celia R A MouzouviPatrick Saulnier
Jan 19, 2018·Scientific Reports·Lígia Nunes de Morais RibeiroEneida de Paula
Feb 15, 2018·Journal of Nanoscience and Nanotechnology·Nathalie Ferreira Silva de MeloLeonardo Fernandes Fraceto
Aug 31, 2018·Journal of Oral and Maxillofacial Pathology : JOMFP·Syed Ahmed TaqiSyed Ahmed Zaki
Oct 12, 2018·Pharmaceutical Research·Juliana Damasceno OliveiraEneida de Paula
Nov 10, 2018·International Journal of Nanomedicine·Lígia Nunes de Morais RibeiroEneida de Paula

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Felipe A Oyarzun-AmpueroDolores Torres
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
Luiza A FrankS S Guterres
© 2021 Meta ULC. All rights reserved